Jack Yongfeng Zhang
2017
In 2017, Jack Yongfeng Zhang earned a total compensation of $5.8M as Chief Executive Officer, Chief Scientific Officer and Director at Amphastar Pharmaceuticals, which was about the same as previous year.
Compensation breakdown
| Bonus | $668,454 |
|---|---|
| Option Awards | $2,090,004 |
| Salary | $880,000 |
| Stock Awards | $2,089,996 |
| Other | $27,078 |
| Total | $5,755,532 |
Zhang received $2.1M in option awards, accounting for 36% of the total pay in 2017.
Zhang also received $668.5K in bonus, $880K in salary, $2.1M in stock awards and $27.1K in other compensation.
Rankings
In 2017, Jack Yongfeng Zhang's compensation ranked 1,550th out of 14,666 executives tracked by ExecPay. In other words, Zhang earned more than 89.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,550 out of 14,666 | 89th |
Division Manufacturing | 519 out of 5,768 | 91st |
Major group Chemicals And Allied Products | 137 out of 2,074 | 93rd |
Industry group Drugs | 99 out of 1,730 | 94th |
Industry Pharmaceutical Preparations | 78 out of 1,329 | 94th |
Source: SEC filing on April 18, 2018.
Zhang's colleagues
We found two more compensation records of executives who worked with Jack Yongfeng Zhang at Amphastar Pharmaceuticals in 2017.
News
Amphastar Pharmaceuticals CEO Jack Zhang's 2021 pay rises 9% to $6.5M
April 14, 2022
Amphastar Pharmaceuticals General Counsel Jason Shandell's 2020 pay jumps 132% to $6.8M
April 14, 2021
Amphastar Pharmaceuticals CEO Jack Zhang's 2019 pay rises 2% to $6M
April 15, 2020
Amphastar Pharmaceuticals CEO Jack Zhang's 2018 pay rises 2% to $5.9M
April 18, 2019